Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 10, 2024

SELL
$0.04 - $0.13 $400 - $1,300
-10,000 Reduced 13.25%
65,500 $4,000
Q1 2023

Apr 26, 2023

BUY
$0.46 - $0.81 $2,300 - $4,050
5,000 Added 7.09%
75,500 $47,000
Q4 2022

Feb 03, 2023

SELL
$0.5 - $261.0 $4,275 - $2.23 Million
-8,550 Reduced 10.82%
70,500 $45,000
Q3 2022

Oct 11, 2022

BUY
$1.04 - $322.5 $2,600 - $806,250
2,500 Added 3.27%
79,050 $136,000
Q2 2022

Jul 12, 2022

BUY
$0.41 - $1.24 $31,385 - $94,922
76,550 New
76,550 $95,000
Q1 2022

Apr 25, 2022

SELL
$0.62 - $1.17 $39,711 - $74,938
-64,050 Closed
0 $0
Q4 2021

Jan 20, 2022

BUY
$1.09 - $1.89 $32,482 - $56,322
29,800 Added 87.01%
64,050 $70,000
Q2 2021

Jul 20, 2021

BUY
$2.63 - $3.67 $26,300 - $36,700
10,000 Added 41.24%
34,250 $90,000
Q4 2019

Jan 29, 2020

BUY
$3.95 - $5.35 $95,787 - $129,737
24,250 New
24,250 $114,000

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $458M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Sugarloaf Wealth Management, LLC Portfolio

Follow Sugarloaf Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sugarloaf Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sugarloaf Wealth Management, LLC with notifications on news.